Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.

Stress is known to modulate sensitisation to repeated psychostimulant exposure. However, there is no direct evidence linking glucocorticoids and sensitisation achieved by repeated administration of the NMDA receptor antagonist MK-801. We tested the hypothesis that co-administration of RU486, a gluco...

Full description

Bibliographic Details
Main Authors: Emilia M Lefevre, Gregory A Medley, Timothy Reeks, Suzy Alexander, Thomas H J Burne, Darryl W Eyles
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5400269?pdf=render
_version_ 1818267331502014464
author Emilia M Lefevre
Gregory A Medley
Timothy Reeks
Suzy Alexander
Thomas H J Burne
Darryl W Eyles
author_facet Emilia M Lefevre
Gregory A Medley
Timothy Reeks
Suzy Alexander
Thomas H J Burne
Darryl W Eyles
author_sort Emilia M Lefevre
collection DOAJ
description Stress is known to modulate sensitisation to repeated psychostimulant exposure. However, there is no direct evidence linking glucocorticoids and sensitisation achieved by repeated administration of the NMDA receptor antagonist MK-801. We tested the hypothesis that co-administration of RU486, a glucocorticoid receptor (GR) antagonist, prior to repeated daily MK-801 injections would block the expression of locomotor sensitisation due to its dual effects on corticosterone and dopamine. We employed a repeated MK-801 administration locomotor sensitisation paradigm in male Sprague Dawley rats. RU486 or a dimethyl sulfoxide (DMSO) vehicle was co-administered with MK-801 or saline during the induction phase. Subsequent to withdrawal, rats were challenged with MK-801 alone to test for the expression of sensitisation. In a separate cohort of rats, plasma corticosterone levels were quantified from blood samples taken on the 1st, 4th and 7th day of induction and at expression. One day after challenge, nucleus accumbens tissue levels of dopamine and its metabolites DOPAC and HVA were measured. During the induction phase, RU486 progressively enhanced locomotor sensitisation to MK-801. RU486 and MK-801 both showed stimulatory effects on corticosterone levels and this was further augmented when given in combination. Contrary to our hypothesis, RU486 did not block the expression of locomotor sensitisation to MK-801 and actually increased levels of dopamine, DOPAC and HVA in nucleus accumbens tissue. Our results showed that RU486 has augmentative rather than inhibitory effects on MK-801-induced sensitisation. This study indicates a divergent role for glucocorticoids in sensitisation to MK-801 compared to sensitisation with other psychostimulants.
first_indexed 2024-12-12T20:20:54Z
format Article
id doaj.art-b94d02aed5184ddebce59e6c4ac1a793
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T20:20:54Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b94d02aed5184ddebce59e6c4ac1a7932022-12-22T00:13:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017615610.1371/journal.pone.0176156Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.Emilia M LefevreGregory A MedleyTimothy ReeksSuzy AlexanderThomas H J BurneDarryl W EylesStress is known to modulate sensitisation to repeated psychostimulant exposure. However, there is no direct evidence linking glucocorticoids and sensitisation achieved by repeated administration of the NMDA receptor antagonist MK-801. We tested the hypothesis that co-administration of RU486, a glucocorticoid receptor (GR) antagonist, prior to repeated daily MK-801 injections would block the expression of locomotor sensitisation due to its dual effects on corticosterone and dopamine. We employed a repeated MK-801 administration locomotor sensitisation paradigm in male Sprague Dawley rats. RU486 or a dimethyl sulfoxide (DMSO) vehicle was co-administered with MK-801 or saline during the induction phase. Subsequent to withdrawal, rats were challenged with MK-801 alone to test for the expression of sensitisation. In a separate cohort of rats, plasma corticosterone levels were quantified from blood samples taken on the 1st, 4th and 7th day of induction and at expression. One day after challenge, nucleus accumbens tissue levels of dopamine and its metabolites DOPAC and HVA were measured. During the induction phase, RU486 progressively enhanced locomotor sensitisation to MK-801. RU486 and MK-801 both showed stimulatory effects on corticosterone levels and this was further augmented when given in combination. Contrary to our hypothesis, RU486 did not block the expression of locomotor sensitisation to MK-801 and actually increased levels of dopamine, DOPAC and HVA in nucleus accumbens tissue. Our results showed that RU486 has augmentative rather than inhibitory effects on MK-801-induced sensitisation. This study indicates a divergent role for glucocorticoids in sensitisation to MK-801 compared to sensitisation with other psychostimulants.http://europepmc.org/articles/PMC5400269?pdf=render
spellingShingle Emilia M Lefevre
Gregory A Medley
Timothy Reeks
Suzy Alexander
Thomas H J Burne
Darryl W Eyles
Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.
PLoS ONE
title Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.
title_full Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.
title_fullStr Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.
title_full_unstemmed Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.
title_short Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.
title_sort effect of the glucocorticoid receptor antagonist ru486 on mk 801 induced behavioural sensitisation
url http://europepmc.org/articles/PMC5400269?pdf=render
work_keys_str_mv AT emiliamlefevre effectoftheglucocorticoidreceptorantagonistru486onmk801inducedbehaviouralsensitisation
AT gregoryamedley effectoftheglucocorticoidreceptorantagonistru486onmk801inducedbehaviouralsensitisation
AT timothyreeks effectoftheglucocorticoidreceptorantagonistru486onmk801inducedbehaviouralsensitisation
AT suzyalexander effectoftheglucocorticoidreceptorantagonistru486onmk801inducedbehaviouralsensitisation
AT thomashjburne effectoftheglucocorticoidreceptorantagonistru486onmk801inducedbehaviouralsensitisation
AT darrylweyles effectoftheglucocorticoidreceptorantagonistru486onmk801inducedbehaviouralsensitisation